Every golfer has too many old stained polos and shorts with holes in them. Modernize your golf wardrobe with these seven pieces of golf apparel ...

This should be more compatative in comparison to thar and scorpion N. It's road presence is good bit sitting comfort is compromised. Some digital ...

When the rat rounded a corner for the first time, it would encounter the robot scorpion. The Lego creature sported a pincher ... In these situations, they recorded impulses directed both toward parts ...

Ever wondered how gem-like lollipops with a scorpion inside are made? Here's how and why they've become so popular in Arizona, despite being imports.

The actual lollipop is no joke. We spent a good thirty minutes trying to lick our way down to the scorpion. But because some parts of the scorpion were closer to the surface, at one point ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.

Eli Lilly has turned to a biotechnology startup for help building its pipeline of cancer drugs, agreeing on Monday to purchase an experimental cancer drug from privately held Scorpion Therapeutics for ...

Eli Lilly (NYSE:LLY) is in advanced discussions to purchase cancer-focused biotech Scorpion Therapeutics for as much as $2.5 billion. A deal is likely to be reached in the coming days ahead of the ...